Abstract
We present a theoretical study of superficial bladder cancer growth and its treatment via pulsed immunotherapy with Bacillus Calmette–Guérin (BCG), an attenuated strain of Mycobacterium bovis. BCG pulsed immunotherapy is a clinically established procedure for the treatment of superficial bladder cancer. In this paper, periodic BCG instillations are modeled using impulsive differential equations, which are studied using a combination of analytical and numerical techniques. In this way, we determine critical threshold values of the BCG instillation dose and rate of pulsing for successful treatment. We also identify treatment regimes in which tumor destruction occurs, but undesirable side effects are maintained at low levels by the immune system.
Similar content being viewed by others
References
Alexandroff, A.B., Jackson, A.M., O’Donnell, M.A., James, K., 1999. BCG immunotherapy of bladder cancer: 20 years on. Lancet 353, 1689.
Archuleta, J., Mullens, P., Primm, T.P., 2002. The relationship of temperature to desiccation and starvation tolerance of the Mycobacterium avium complex. Arch. Microbiol. 178, 311–14.
Bainov, D., 1993. Impulsive Differential Equations. Longman, Harlow.
Bevers, R.F.M., Kurth, K.H., Schamhart, D.H.J., 2004. Role of urothelial cells in BCG immunotherapy for superficial bladder cancer. Br. J. Cancer 91, 607–12.
Bohle, A., Brandau, S., 2003. Immune mechanisms in bacillus Calmette–Guérin immunotherapy for superficial bladder cancer. J. Urol. 170, 964969.
Bunimovich-Mendrazitsky, S., Shochat, E., Stone, L., 2007. Mathematical model of BCG immunotherapy in superficial bladder cancer. Bull. Math. Biol. Online: http://dx.doi.org/10.1007/s11538-007-9195-z
Cheng, C.W., Ng, M.T., Chan, S.Y., Sun, W.H., 2004. Low dose BCG as adjuvant therapy for superficial bladder cancer and literature review. ANz J. Surg. 74(7), 569–72.
Chopin, D., Gattegno, B., 2002. Superficial bladder tumors. Eur. Urol. 42, 533–1.
De Boer, E.C., Bevers, R.F., Kurth, K.H., Schamhart, D.H., 1996. Double fluorescent flow cytometric assessment of bacterial internalization and binding by epithelial cells. Cytometry 25, 381–87.
De Pillis, L.G., Radunskaya, A.E., Wiseman, C.L., 2005. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res. 65(17), 7950–958.
De Pillis, L.G., Gu, W., Radunskaya, A.E., 2006. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations. J. Teor. Biol. 238, 841–62.
Durek, C., Brandau, S., Ulmer, A.J., Flad, H.D., Jocham, D., Bohle, A., 1999. Bacillus Calmette–Guérin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion. J. Urol. 162, 600–05.
Glendinning, P., 1994. Stability, Instability and Chaos: An Introduction to the Theory of Nonlinear Differential Equations. Cambridge University Press, Cambridge.
Guckenheimer, J., Holmes, P., 1983. Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields. Springer, New York.
Hartman, P., 1964. Ordinary Differential Equations. Wiley, New York.
Iooss, G., Joseph, D., 1980. Elementary Stability and Bifurcation Theory. Springer, New York.
Kim, J.C., Steinberg, G.D., 2001. The limits of bacillus Calmette–Guerin for carcinoma in situ of the bladder. J. Urol. 165(3), 745–56.
Kirschner, D., Panetta, J., 1998. Modelling immunotherapy of the tumor-immune interaction. J. Math. Biol. 37(3), 235–52.
Kuznetsov, V.A., Makalkin, I.A., Taylor, M.A., Perelson, A.S., 1994. Nonlinear dynamics of immunogenic tumours: parameter estimation and global bifurcation analysis. Bull. Math. Biol. 56, 295–21.
Lakmeche, A., Arino, O., 2001. Nonlinear mathematical model of pulsed therapy of heterogeneous tumors. Nonlinear Anal. R. World Appl. 2, 455–65.
Lakshmikantham, V., Bainov, D.D., Simeonov, P.S., 1989. Theory of Impulsive Differential Equations. World Publishers, Singapore.
Lämmle, M., Beer, A., Settles, M., Hanning, C., Schwaibold, H., Drews, C., 2002. Reliability of MR imaging-based virtual cystoscopy in the diagnosis of cancer of the urinary bladder. Am. J. Roentgenol. 178, 1483–488.
Mackey, M., Glass, L., 1977. Oscillation and chaos in physiological control systems. Science 197, 287–89.
Meyer, J.P., Persad, R., Gillatt, D.A., 2002. Use of bacille Calmette–Guérin in superficial bladder cancer. Postgrad. Med. J. 78, 449–54.
Murray, J.D., 1993. Mathematical Biology, 2nd edn. Springer, London.
Nseyo, U.O., Lamm, D.L., 1997. Immunotherapy of Bladder Cancer. Sem. Surg. Oncol. 13, 342–49.
Ojea, A., Nogueira, J.L., Solsona, E., et al., 2007. A multicentre, randomized prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette–Guérin (27 mg) versus very low-dose bacillus Calmette–Guérin (13.5 mg) versus mitomycin C. Eur. Urol. 52, 1398–06.
Panetta, J., 1996. A mathematical model of periodically pulse chemotherapy: tumor recurrence and metastasis in a competition environment. Bull. Math. Biol. 58, 425–47.
Patard, J.J., Saint, F., Velotti, F., Abbou, C.C., Chopin, D.K., 1998. Immune response following intravesical bacillus Calmette–Guérin instillations in superficial bladder cancer: a review. Urol. Res. 26(3), 155–59.
Schenk-Braat, E.A.M., Bangma, C.H., 2005. Immunotherapy for superficial bladder cancer. Cancer Immunol. Immunother. 54(5), 414–23.
Shulgin, B., Stone, L., Agur, Z., 1998. Pulse vaccination strategy in the SIR epidemic model. Bull. Math. Biol. 60, 1–6.
Stone, L., Shulgin, B., Agur, Z., 2000. Theoretical examination of the pulse vaccination policy in the SIR epidemic model. Math. Comput. Mod. 31(4–), 207–15.
Schenkman, E., Lamm, D.L., 2004. Superficial bladder cancer therapy. Sci. World 4, 387–99.
Shochat, E., Hart, D., Agur, Z., 1999. Using computer simulations for evaluating the efficacy of breast cancer chemotherapy protocols. Math. Models Methods Appl. Sci. 9(4), 599–15.
Swanson, K.R., Bridge, C., Murray, J.D., Alvord, E.C., 2003. Virtual and real brain tumors:using mathematical modeling to quantify glioma growth and invasion. J. Neurol. Sci. 216, 1–0.
Zlotta, A.R., van Vooren, J.P., Huygen, K., et al., 2000. What is the optimal regimen for BCG intravesical therapy? Eur. Urol. 37, 470.
Zwillinger, D., 1989. Handbook of Differential Equations. Academic Press, New York.
Wigginton, J., Kirschner, D., 2001. A model to predict cell-mediated immune regulatory mechanisms during human infection with Mycobacterium tuberculosis. J. Immunol. 166, 1951–967.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bunimovich-Mendrazitsky, S., Byrne, H. & Stone, L. Mathematical Model of Pulsed Immunotherapy for Superficial Bladder Cancer. Bull. Math. Biol. 70, 2055–2076 (2008). https://doi.org/10.1007/s11538-008-9344-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11538-008-9344-z